The Gyrolab platform for immunogenicity assessment and biotherapeutic and biomarker analysis: technical advances and

Yuji Mano1,2, Kei Nabeshima3, Tomoko Kojima3

  • 1Global Drug Metabolism and Pharmacokinetics, Eisai Co., Ltd., Tsukuba, Japan.

Bioanalysis
|June 25, 2026
PubMed

Related Concept Videos